Zhou, F., Liu, Y.-M., Xie, J., Li, H., Lei, F., Yang, H., … Xia, J. (2020). Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality. Hypertension, 76(2), e15–e17. https://doi.org/10.1161/HYPERTENSIONAHA.120.15622

Zhou, Feng, Ye-Mao Liu, Jing Xie, Haomiao Li, Fang Lei, Huilin Yang, Juan-Juan Qin, et al. “Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.” Hypertension 76, no. 2 (August 2020): e15–17. https://doi.org/10.1161/HYPERTENSIONAHA.120.15622.

Zhou F, Liu Y-M, Xie J, Li H, Lei F, Yang H, et al. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality. Hypertension. 2020 Aug;76(2):e15–7.

Zhou, Feng, et al. “Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.” Hypertension, vol. 76, no. 2, Aug. 2020, pp. e15–17. Pubmed, doi:10.1161/HYPERTENSIONAHA.120.15622.

Zhou F, Liu Y-M, Xie J, Li H, Lei F, Yang H, Qin J-J, Cai J, Zhang X-J, Wu B, Xia M, Xiang D, Yang C, Ma X, Xu Q, Lu Z, Lu H, Xia X, Wang D, Liao X, Peng G, Yang J, Huang X, Zhang B-H, Yuan Y, Wei X, Liu PP, Wang Y, Zhang P, She Z-G, Xia J. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality. Hypertension. 2020 Aug;76(2):e15–e17.